| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Akt in cancer: Mediator and more
|
Revathidevi, Sundaramoorthy
|
|
|
59 |
C |
p. 80-91
|
artikel
|
| 2 |
Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
|
Marzagalli, Monica
|
|
|
59 |
C |
p. 221-235
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
59 |
C |
p. ii
|
artikel
|
| 4 |
Emerging role of PI3K/AKT in tumor-related epigenetic regulation
|
Yang, Qi
|
|
|
59 |
C |
p. 112-124
|
artikel
|
| 5 |
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
|
Queirolo, Paola
|
|
|
59 |
C |
p. 290-297
|
artikel
|
| 6 |
Mechanisms of PTEN loss in cancer: It’s all about diversity
|
Álvarez-Garcia, Virginia
|
|
|
59 |
C |
p. 66-79
|
artikel
|
| 7 |
Metabolic flexibility in melanoma: A potential therapeutic target
|
Ruocco, Maria Rosaria
|
|
|
59 |
C |
p. 187-207
|
artikel
|
| 8 |
MicroRNA heterogeneity in melanoma progression
|
Thyagarajan, Anita
|
|
|
59 |
C |
p. 208-220
|
artikel
|
| 9 |
mTOR: Role in cancer, metastasis and drug resistance
|
Murugan, Avaniyapuram Kannan
|
|
|
59 |
C |
p. 92-111
|
artikel
|
| 10 |
Natural melanoma-derived extracellular vesicles
|
Hood, Joshua L.
|
|
|
59 |
C |
p. 251-265
|
artikel
|
| 11 |
New insights in melanoma biology: Running fast towards precision medicine
|
Limonta, Patrizia
|
|
|
59 |
C |
p. 161-164
|
artikel
|
| 12 |
Phosphoinositide phosphatases in cancer cell dynamics—Beyond PI3K and PTEN
|
Ijuin, Takeshi
|
|
|
59 |
C |
p. 50-65
|
artikel
|
| 13 |
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
|
Alzahrani, Ali S.
|
|
|
59 |
C |
p. 125-132
|
artikel
|
| 14 |
PIK3CA in cancer: The past 30 years
|
Arafeh, Rand
|
|
|
59 |
C |
p. 36-49
|
artikel
|
| 15 |
RAS mutations in human cancers: Roles in precision medicine
|
Murugan, Avaniyapuram Kannan
|
|
|
59 |
C |
p. 23-35
|
artikel
|
| 16 |
Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer
|
Sharma, VarRuchi
|
|
|
59 |
C |
p. 133-146
|
artikel
|
| 17 |
Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer
|
Jiang, Wei
|
|
|
59 |
C |
p. 3-22
|
artikel
|
| 18 |
Role of angiogenesis in melanoma progression: Update on key angiogenic mechanisms and other associated components
|
Cho, Woo Cheal
|
|
|
59 |
C |
p. 175-186
|
artikel
|
| 19 |
Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
|
Ediriweera, Meran Keshawa
|
|
|
59 |
C |
p. 147-160
|
artikel
|
| 20 |
Special issue: PI3K/Akt signaling in human cancer
|
Murugan, Avaniyapuram Kannan
|
|
|
59 |
C |
p. 1-2
|
artikel
|
| 21 |
The adjuvant treatment revolution for high-risk melanoma patients
|
Spagnolo, Francesco
|
|
|
59 |
C |
p. 283-289
|
artikel
|
| 22 |
The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers
|
Donnelly III, Douglas
|
|
|
59 |
C |
p. 165-174
|
artikel
|
| 23 |
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
|
Marzagalli, Monica
|
|
|
59 |
C |
p. 236-250
|
artikel
|
| 24 |
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma
|
Fontana, Fabrizio
|
|
|
59 |
C |
p. 266-282
|
artikel
|
Tijdschrift beschrijving